U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285473) titled 'Low-Dose Naltrexone For ME/CFS: Dose-Finding' on Dec. 09.
Brief Summary: This exploratory clinical trial tests low-dose naltrexone (LDN) for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A remote trial approach is used, with eligibility open to the entire U.S.
Study Start Date: April 01, 2026
Study Type: INTERVENTIONAL
Condition:
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Intervention:
DRUG: Low-Dose Naltrexone, 1.5mg
Low-Dose Naltrexone (LDN) is not a commercially available drug and will be compounded for this study. LDN will be taken orally, up to once per day.
DRUG: Low-Dose Naltrex...